Shareholders’ Equity (Details Narrative) - USD ($)						1 Months Ended		3 Months Ended					9 Months Ended
Shareholders’ Equity (Details Narrative) - USD ($)	Jul. 02, 2025	Jun. 03, 2025	Oct. 11, 2024	Jan. 01, 2024	Dec. 01, 2023	Feb. 28, 2025	Dec. 31, 2023	Sep. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2025	Sep. 30, 2024	Mar. 13, 2025	Dec. 31, 2024
Class of Stock [Line Items]
Gross proceeds													$ 2,635,330	$ 6,669,860
Shares authorized													6,265,769
Description of debt conversion					The Series F Convertible Preferred Stock is convertible shares of our common stock in accordance with the Certificate of Designation for the Series F Convertible Preferred Stock
Short-term notes payable, net of debt issuance costs								$ 394,836					$ 394,836			$ 328,528
Preferred stock par value								$ 0					$ 0			$ 0
Stockholders equity reverse stock split		1-for-30
Proceeds from issuance of preferred stock and warrants	$ 15,200,000												$ 15,200,000
Issuance of warrants								677,687					677,687
Common Stock [Member]
Class of Stock [Line Items]
Shares authorized									258,849	126,895	36,667	46,667
Conversion shares													249,624
Conversion of stock issued, shares								3,304,246					3,304,246
Warrant [Member]
Class of Stock [Line Items]
Issuance of warrants								1,764					1,764
Series F Preferred Stock [Member]
Class of Stock [Line Items]
Shares authorized				511,308			8,000,000
Issuance of converted stock				17,044
Conversion of preferred stock into common stock								7,488,692					7,488,692
Conversion shares													7,488,692
Series H preferred stock shares, outstanding								7,488,692					7,488,692			7,488,692
Series G Preferred Stock [Member]
Class of Stock [Line Items]
Shares authorized									1,000,000
Short-term notes payable, net of debt issuance costs									$ 3,000,000.0
Preferred stock par value									$ 0
Share price									$ 0.10
Stockholders equity reverse stock split													On May 2, 2025, upon our shareholders’ approval, at our annual shareholders meeting, of a proposal authorizing the Company’s Board of Directors, in its discretion at any time within one year after shareholder approval is obtained, to effect a Reverse Stock Split of then-outstanding shares of the Company’s common stock, at a ratio of not less than one-for-five (1:5) and not greater than one-for-sixty (1:60), with the exact ratio to be determined by the Company’s Board and included in a public announcement (the “Reverse Split Proposal”), in accordance with the Certificate of Designation creating the Series G Mirroring Preferred Stock, all of the shares of Series G Mirroring Preferred Stock were automatically transferred to the Company and cancelled and such shares have resumed the status of authorized but unissued shares of preferred stock and are no longer designated as Series G Preferred Stock
Number of shares issued															1,000,000
Series H Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, stated value	$ 25.00
Conversion price	$ 2.50
Series H preferred stock shares, outstanding								432,122					432,122			0
Conversion of stock issued, shares													227,878
Series H Preferred Stock [Member] \| Warrant [Member]
Class of Stock [Line Items]
Gross from issuance of preferred stock and warrants	$ 16,500,000
Proceeds from issuance of preferred stock and warrants	$ 15,200,000
Number of shares issued	660,000
Preferred stock, stated value	$ 25.00
Issuance of warrants	660,000
Exercise price	$ 25.00
Conversion price	$ 2.50
ATM Agreement [Member] \| Dawson James Securities Inc [Member]
Class of Stock [Line Items]
Commission percentage			3.00%
At The Market Sales Agreement [Member] \| Dawson James Securities Inc [Member]
Class of Stock [Line Items]
Sale of stock						260,000
Gross proceeds						$ 2,600,000
Payment of legal fees						$ 110,000

ORAGENICS INC 10-Q